Clinical Trials Browser

Phase NA × Active not recruiting × Fluorodeoxyglucose F18 × Clear all

NCT02226276 2026-02-13

Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer

Phase NA Active not recruiting

10 enrolled 8 charts

Breast Neoplasms

NCT04251481 2026-01-22

Diffusion MRI for Head and Neck Cancer

Phase NA Active not recruiting

Head and Neck Neoplasms